8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Elevance Health raises 2026 guidance after third-quarter earnings increase
Filed with the SEC on · Summarized by InvestorsBot
Elevance Health reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7% year over year, with diluted EPS of $6.27 and adjusted diluted EPS of $6.99. The company raised full-year 2026 guidance to at least $22.00 in diluted EPS, $29.00 in adjusted diluted EPS and $6.5 billion in operating cash flow, while Carelon operating gain rose 17% to $0.9 billion and Health Benefits operating gain fell 28% to $0.4 billion. The board also declared a $1.72 per-share dividend payable December 18, 2026, and Elevance repurchased $330 million of stock during the quarter.